{"name":"PegBio Co., Ltd.","slug":"pegbio-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PB-201","genericName":"PB-201","slug":"pb-201","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"PB-201","genericName":"PB-201","slug":"pb-201","phase":"phase_3","mechanism":"PB-201 is a PEGylated biologic therapeutic designed to modulate immune function or target a specific disease pathway.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQWHhrV0lSZS1IcGI3MVF1MUtNUDJZdDNCWmZZNUZrNHlKNXVJUUxTa2k5cElXQVkzSnFWdlF4OGhrYk9zeVdTeFRmT2lmQU5zSWsxQkwtT0hJb3lNOGlQa09xb3RIdk52dEpwVmUtMUhSc3BWOGZ2WllOcFR0Zl9kbk1lVF9nQQ?oc=5","date":"2026-04-02","type":"pipeline","source":"AASTOCKS.com","summary":"PEGBIO CO-B-50 (02565) has dropped 8.713%. The last price is HK$47.88AA Market Move - Price Dropped - AASTOCKS.com","headline":"PEGBIO CO-B-50 (02565) has dropped 8.713%. The last price is HK$47.88AA Market Move - Price Dropped","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFAwY3ZOWWJ0Z3I3VUZ6VjZhZ3ZoaXIyUUZrVDhxWkVOZWhTdEJibG5idk1tV1h2Tzhwa3p5bUxYQ0ZaUmZOcVRRWXlMNGI3YTI4Zkx5QXFEbnk1YkVudXNDQ09ubXJKMks3ZHZv?oc=5","date":"2026-02-06","type":"earnings","source":"Insightace Analytic","summary":"GLP-1 Market Size, Share, Trend, Revenue Report 2026 to 2035 - Insightace Analytic","headline":"GLP-1 Market Size, Share, Trend, Revenue Report 2026 to 2035","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"pipeline","source":"GlobeNewswire","summary":"GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global - GlobeNewswire","headline":"GLP-1 Agonists (Ozempic, Wegovy, Mounjaro) Market - Global","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOd1p5eUVSN2hiWWtQVTRtdUpxaWExSXZ6OHJfd3U4eFVrWFdxeGtLMlNUa2diSFZBeFZ2bTJQb1U4Z3pVNDQzRldaMUhtSVQ1bHZMY0FabXZaOUhBNFV3bDI1NEdnWC0zaXhuWmRmRXFVMzJIc29hMmlFeU5Pd0QxYzRUWTkzbVE?oc=5","date":"2025-09-19","type":"pipeline","source":"BioWorld News","summary":"Genfleet raises $234M with Hong Kong IPO - BioWorld News","headline":"Genfleet raises $234M with Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQbTBYUFotVDBCU2ZNSEhqc0Y4VUkwS2t1UmR3MnNibXBWSWdJTWNuUGJWajBoNHllRzA2blJ6UEk0QWRVUEFVeDVfM3JkdEZ3Vk5lYVAwOVFkQmt6WUdxeEt5VHBvV3BVVXpFc3l2dFc2WGlFeTZ2aXF4b2I2anNiRVNsVnI4cndqczd3dG1FSC1yLU9fUTI3WmxkekdtOFh4d1MxSQ?oc=5","date":"2025-06-24","type":"pipeline","source":"BioWorld News","summary":"Transthera raises $25M with Hong Kong IPO; stock up 78% on debut - BioWorld News","headline":"Transthera raises $25M with Hong Kong IPO; stock up 78% on debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQMDFWdFVoMXZ3SFp5LVFfOTdyS0dPaG9NNVdMOWpqTkdRT0hjMFFyZmNPN0hEcjVZMEpMc3pmZ3NqZk1JejF4MjVLVnZnbHI5QTlfVXAyRjlWSDJWeDFmcXZmZlNubE1laEZUM2RQZHItLXFsaWhGYW5odUtfZ09sTVp3eTNSWnlsaUlNQw?oc=5","date":"2025-05-20","type":"pipeline","source":"BioWorld News","summary":"China’s Pegbio launches HK$300M Hong Kong IPO - BioWorld News","headline":"China’s Pegbio launches HK$300M Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQV1E1RWROakFRS2xOMkVYRnd3T0x6ejVfcEtmZ3VXN2xaX0d3a2JXUFlFSG5TN3RucDhUZlhPeGFnZzFrODlLeUV0N2hrWlVYMU8zMkVTaU5ZYklEUTJxZ0N4VzhrUUFmazBWdXRSSXV4WHE5UXFzaWNmTnNQSkpBQ2dsOE01Zkd2bm95eW1wbTdOUQ?oc=5","date":"2024-12-13","type":"pipeline","source":"thebambooworks.com","summary":"Innogen Pharma jostles for a slice of the weight-loss market - thebambooworks.com","headline":"Innogen Pharma jostles for a slice of the weight-loss market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNLVphSUYyb19XalJIeTdKb3VJRmFCN1F3ZUVtMGhaeFozR3B2THRsblQyYW1zcjFfSVZWMXRmRGtSVmdRSmxzV3FHNXV1amVFWE5VcVhmUlBzMWhPQUhhUVlCbkxkZEk5MTBMUzg4MEFLV1NrTGpqbEtqbHNuRmZGclZDNVgwQS12YlNoNkUwMnJoandxZmFXOGlWcml0dWlSYWsweVVPSnJKaG1kOFU1MnV2NkQwXzM0b3EzQV9uSTliY1ZsZW1OMkRncjJUS21fSmd3?oc=5","date":"2024-06-05","type":"patent","source":"Reuters","summary":"Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic - Reuters","headline":"Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}